Table 4.
Lipid profile
|
Lipid profile
|
Group
|
Baseline period
|
Ingestion period
|
P
value
|
| Cholesterol (mg/dL) | Probiotic-treated | 194.93 ± 37.64 | 192.20 ± 36.55 | 0.462 |
| Placebo | 193.70 ± 29.47 | 192.37 ± 29.75 | 0.412 | |
| Triglyceride (mg/dL) | Probiotic-treated | 151.50 ± 63.92 | 166.83 ± 75.02 | 0.162 |
| Placebo | 191.40 ± 133.60 | 187.73 ± 111.58 | 0.542 | |
| HDL (mg/dL) | Probiotic-treated | 40.33 ± 9.77 | 40.00 ± 9.28 | 0.691 |
| Placebo | 39.93 ± 7.29 | 40.60 ± 8.18 | 0.391 | |
| LDL (mg/dL) | Probiotic-treated | 141.43 ± 32.17 | 136.97 ± 33.12 | 0.182 |
| Placebo | 134.50 ± 24.84 | 133.50 ± 27.06 | 0.711 | |
| Ratio of LDL/HDL | Probiotic-treated | 3.63 ± 0.95 | 3.55 ± 0.87 | 0.381 |
| Placebo | 3.44 ± 0.70 | 3.39 ± 0.84 | 0.611 |
1
Paired t-test.
2
Wilcoxon signed-rank test. A significantly different (P < 0.05). LDL: Low-density lipoprotein; HDL: High-density lipoprotein.